Ubiquitous importance of protein glycosylation

Methods in Molecular Biology

Volumn 1503, Issue , 2017, Pages 1-12

  Krištić, Jasminka ^a   Lauc, Gordan ^a,b  

^a GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Alternative glycosylation; Glycans; Glycosylation in disease; IgG glycosylation; Lectins; O GlcNAc; Protein function; Protein half life; Protein structure

Indexed keywords

GLUCOSE TRANSPORTER 2; GLUCURONIC ACID; GLYCAN; GLYCOPROTEIN; MANNOSE; N ACETYLGLUCOSAMINE; RECOMBINANT ERYTHROPOIETIN; IMMUNOGLOBULIN G; LECTIN; POLYSACCHARIDE; PROTEIN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; APOPTOSIS; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIGNALING ASSAY; DISEASE PREDISPOSITION; HORMONE ACTION; HOST PATHOGEN INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; CARBOHYDRATE ANALYSIS; CHEMISTRY; GLYCOSYLATION; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN PROCESSING;

AMINO ACID SEQUENCE; ANIMALS; CARBOHYDRATE SEQUENCE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; LECTINS; PHOSPHORYLATION; POLYSACCHARIDES; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS;

EID: 84991690981     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-6493-2_1     Document Type: Chapter

References (80)

1. Apweiler R, Hermjakob H, Sharon N (1999) On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1473:4-8
2. Roth J (2002) Protein N-Glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. Chem Rev 102:285-304
3. Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71:435-471
4. Cummings RD (2009) The repertoire of glycan determinants in the human glycome. Mol Biosyst 5:1087-1104
5. Varki A (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3:97-130.
6. Ohtsubo K, Marth JD (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126:855-867
7. Krištić J, Zoldoš V, Lauc G (2014) Complex genetics of protein N-glycosylation. In: Endo T, Seeberger PH, Hart GW, Wong CH, Taniguchi N (eds) Glycoscience: biology and medicine. Springer, Japan
8. Varki A (2011) Evolutionary forces shaping the Golgi glycosylation machinery: why cell surface glycans are universal to living cells. Cold Spring Harb Perspect Biol 3:5462
9. Vogel J, Sperandio M, Pries AR, Linderkamp O, Gaehtgens P, Kuschinsky W (2000) Infl uence of the endothelial glycocalyx on cerebral blood fl ow in mice. J Cereb Blood Flow Metab 20:1571-1578
10. Cohen M (2015) Notable aspects of glycanprotein interactions. Biomolecules 5:2056-2072
11. Varki A, Etzler ME, Cummings RD et al (2009) Discovery and classifi cation of glycan-binding proteins. In: Varki A, Cummings RD, Esko JD et al (eds). Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York. http://www.ncbi.nlm.nih.gov/books/NBK1923/
12. Cummings RD, Esko JD (2009) Principles of glycan recognition. In: Varki A, Cummings RD, Esko JD et al (eds). Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York. http://www.ncbi.nlm.nih.gov/books/NBK1950/
13. Nagae M, Yamaguchi Y (2015) Sugar recognition and protein-protein interaction of mammalian lectins conferring diverse functions. Curr Opin Struct Biol 34:108-115
14. Bochner BS, Zimmermann N (2015) Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation. J Allergy Clin Immunol 135:598-608
15. Sperandio M, Gleissner CA, Ley K (2009) Glycosylation in immune cell traffi cking. Immunology 230:97-113
16. Hirakawa J, Tsuboi K, Sato K, Kobayashi M, Watanabe S, Takakura A, Imai Y, Ito Y, Fukuda M, Kawashima H (2010) Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N-and O-glycans in lymphocyte homing. J Biol Chem 285:40864-40878
17. Diekman AB (2003) Glycoconjugates in sperm function and gamete interactions: how much sugar does it take to sweet-talk the egg? Cell Mol Life Sci 60:298-308
18. Pang PC, Chiu PC, Lee CL, Chang LY, Panico M, Morris HR, Haslam SM, Khoo KH, Clark GF, Yeung WS, Dell A (2011) Human sperm binding is mediated by the Sialyl-Lewis(x) oligosaccharide on the zona pellucida. Science 333:1761-1764
19. Suzuki Y (2005) Sialobiology of infl uenza: molecular mechanism of host range variation of infl uenza viruses. Biol Pharm Bull 28: 399-408
20. Hu L, Crawford SE, Czako R, Cortes-Penfi eld NW, Smith DF, Le Pendu J, Estes MK, Prasad BV (2012) Cell attachment protein VP8* of a human rotavirus specifi cally interacts with A-type histoblood group antigen. Nature 485:256-259
21. Glass RI, Parashar UD, Estes MK (2009) Norovirus gastroenteritis. N Engl J Med 361:1776-1785
22. Shukla D, Spear PG (2001) Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J Clin Invest 108:503-510
23. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Borén T (1998) Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373-377
24. Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, Nabi IR, Wrana JL, Dennis JW (2004) Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306:120-124
25. Wide L, Eriksson K, Sluss PM, Hall JE (2009) Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women. J Clin Endocrinol Metab 94:958-964
26. Becker V, Timmer J, Klingmüller U (2012) Receptor dynamics in signaling. Adv Exp Med Biol 736:313-323
27. Lo WY, Lagrange AH, Hernandez CC, Harrison R, Dell A, Haslam SM, Sheehan JH, Macdonald RL (2010) Glycosylation of {beta}2 subunits regulates GABAA receptor biogenesis and channel gating. J Biol Chem 285:31348-31361
28. Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, Marth JD (2005) Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123:1307-1321
29. Wide L, Naessén T, Sundström-Poromaa I, Eriksson K (2007) Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men. J Clin Endocrinol Metab 92:4410-4417
30. Mi Y, Lin A, Fiete D, Steirer L, Baenziger JU (2014) Modulation of mannose and asialoglycoprotein receptor expression determines glycoprotein hormone half-life at critical points in the reproductive cycle. J Biol Chem 289:12157-12167
31. Egrie JC, Browne JK (2001) Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer 84:3-10
32. Byrne B, Donohoe GG, O’Kennedy R (2007) Sialic acids: carbohydrate moieties that infl uence the biological and physical properties of biopharmaceutical proteins and living cells. Drug Discov Today 12:319-326
33. Jeong YT, Choi O, Lim HR, Son YD, Kim HJ, Kim JH (2008) Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression. J Microbiol Biotechnol 18:1945-1952
34. Su D, Zhao H, Xia H (2010) Glycosylationmodifi ed erythropoietin with improved halflife and biological activity. Int J Hematol 91:238-244
35. Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284:770-776
36. Bolós V, Grego-Bessa J, de la Pompa JL (2007) Notch signaling in development and cancer. Endocr Rev 28:339-363
37. Stanley P (2007) Regulation of Notch signaling by glycosylation. Curr Opin Struct Biol 17:530-535
38. Hicks C, Johnston SH, diSibio G, Collazo A, Vogt TF, Weinmaster G (2000) Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2. Nat Cell Biol 2:515-520
39. Yang LT, Nichols JT, Yao C, Manilay JO, Robey EA, Weinmaster G (2005) Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1. Mol Biol Cell 16:927-942
40. Taylor P, Takeuchi H, Sheppard D, Chillakuri C, Lea SM, Haltiwanger RS, Handford PA (2014) Fringe-mediated extension of O-linked fucose in the ligand-binding region of Notch1 increases binding to mammalian Notch ligands. Proc Natl Acad Sci U S A 111:7290-7295
41. Boareto M, Jolly MK, Lu M, Onuchic JN, Clementi C, Ben-Jacob E (2015) Jagged-Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype. Proc Natl Acad Sci U S A 112:E402-E409
42. Schwab I and Nimmerjahn F (2013) Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol 13:176-189
43. Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-infl ammatory activity of immunoglobulin G resulting from Fc sialylation, vol 313. Science, pp. 670-673
44. Niwa R, Hatanaka S, Shoji-Hosaka E, Sakurada M, Kobayashi Y, Uehara A, Yokoi H, Nakamura K, Shitara K (2004) Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of Fcgamma RIIIa functional polymorphism. Clin Cancer Res 10:6248-6255
45. Iida S, Misaka H, Inoue M, Shibata M, Nakano R, Yamane-Ohnuki N, Wakitani M, Yano K, Shitara K, Satoh M (2006) Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa. Clin Cancer Res 12:2879-2887
46. Masuda K, Kubota T, Kaneko E, Iida S, Wakitani M, Kobayashi-Natsume Y, Kubota A, Shitara K, Nakamura K (2007) Enhanced binding affi nity for FcgammaRIIIa of fucosenegative antibody is suffi cient to induce maximal antibody-dependent cellular cytotoxicity. Mol Immunol 44:3122-3131
47. Hart GW, Akimoto Y. The O-GlcNAc modification (2009) In: Varki A, Cummings RD, Esko JD et al (eds). Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York. http://www.ncbi.nlm.nih.gov/books/NBK1954/
48. Hayes BK, Hart GW (1998) Protein O-GlcNAcylation: potential mechanisms for the regulation of protein function. In: Axford JS (ed) Glycoimmunology, Advances in experimental medicine and biology, vol 435, 2 edn. Springer, New York, pp. 85-94
49. Slawson C, Hart GW (2003) Dynamic interplay between O-GlcNAc and O-phosphate: the sweet side of protein regulation. Curr Opin Struct Biol 13:631-636
50. Zeidan Q, Hart GW (2010) The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci 123:13-22
51. Cohen P (2000) The regulation of protein function by multisite phosphorylation—a 25 year update. Trends Biochem Sci 25:596-601
52. Whelan SA, Hart GW (2003) Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation. Circ Res 93:1047-1058
53. Hardivillé S, Hart GW (2014) Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab 20:208-213
54. Lewis BA (2013) O-GlcNAcylation at promoters, nutrient sensors, and transcriptional regulation. Biochim Biophys Acta 1829:1202-1206
55. Comer FI, Hart GW (2000) O-Glycosylation of nuclear and cytosolic proteins: DYNAMIC INTERPLAY BETWEEN O-GlcNAc ANDOPHOSPHATE. J Biol Chem 275:29179-29182
56. Hanover JA (2001) Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J 15:1865-1876
57. Bond MR, Hanover JA (2015) A little sugar goes a long way: the cell biology of O-GlcNAc. J Cell Biol 208:869-880
58. Shafi R, Iyer SP, Ellies LG, O’Donnell N, Marek KW, Chui D, Hart GW, Marth JD (2000) The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci U S A 97:5735-5739
59. Marek KW, Vijay IK, Marth JD (1999) A recessive deletion in the GlcNAc-1-phosphotransferase gene results in periimplantation embryonic lethality. Glycobiology 9:1263-1271
60. Freeze HH (2001) Update and perspectives on congenital disorders of glycosylation. Glycobiology 11:129R-143R
61. Lauc G, Pezer M, Rudan I, Campbell H (2015) Mechanisms of disease: the human N-glycome. Biochim Biophys Acta. doi: 10.1016/j.bbagen.2015.10.016
62. Stowell SR, Ju T, Cummings RD (2015) Protein glycosylation in cancer. Annu Rev Pathol 10:473-510
63. Thanabalasingham G, Huffman JE, Kattla JJ, Novokmet M, Rudan I, Gloyn AL, Hayward C, Adamczyk B, Reynolds RM, Muzinic A, et al. (2013) Mutations in HNF1A result in marked alterations of plasma glycan profi le. Diabetes 62:1329-1337
64. Vučković F, Krištić J, Gudelj Teruel M, Keser T, Pezer M, Pučić-Baković M, Štambuk J, Trbojević-Akmačić I, Barrios C et al (2015) Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. Arthritis Rheumatol 67:2978-2989
65. Trbojević Akmačić I, Ventham NT, Theodoratou E, Vučković F, Kennedy NA, Krištić J, Nimmo ER, Kalla R, Drummond H, Štambuk J, et al. (2015) Infl ammatory bowel disease associates with proinfl ammatory potential of the immunoglobulin G glycome. Infl amm Bowel Dis 21:1237-1247
66. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung AD., Stanworth D, Rademacher TW, Mizuochi T, Taniguchi T, Matsuta K (1985) Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316:452-457
67. Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, Beyer RP, Shi M, Zhang J (2010) Glycoproteomics in neurodegenerative diseases. Mass Spectrom Rev 29:79-125
68. Kreisman LS, Cobb BA (2012) Infection, infl ammation and host carbohydrates: a Glyco-Evasion hypothesis. Glycobiology 22:1019-1030
69. Huffman JE, Pučić-Baković M, Klarić L, Hennig R, Selman MH, Vučković F, Novokmet M, Krištić J, Borowiak M, Muth T, et al. (2014) Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol Cell Proteomics 13:1598-1610
70. Zoldos V, Horvat T, Lauc G (2013) Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies. Curr Opin Chem Biol 17:34-40
71. Taniguchi N, Kizuka Y (2015) Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv Cancer Res 126:11-51
72. Drake PM, Cho W, Li B, Prakobphol A, Johansen E, Anderson NL, Regnier FE, Gibson BW, Fisher SJ (2010) Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem 56:223-236
73. Fuster MM, Esko JD (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5:526-542
74. Dube DH, Bertozzi CR (2005) Glycans in cancer and infl ammation-potential for therapeutics and diagnostics. Nat Rev Drug Discov 4:477-488
75. Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, Polasek O, Gornik O, Supraha-Goreta S, Wormald MR, Redzic I, et al. (2011) High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 10:111010090
76. Knežević A, Polašek O, Gornik O, Rudan I, Campbell H, Hayward C, Wright A, Kolčić I, O’Donoghue N, Bones J, et al. (2009) Variability, heritability and environmental determinants of human plasma N-glycome. J Proteome Res 8:694-701
77. Ogata S, Shimizu C, Franco A, Touma R, Kanegaye JT, Choudhury BP, Naidu NN, Kanda Y, Hoang LT, Hibberd ML, Tremoulet AH, Varki A, Burns JC (2013) Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G. PLoS One 8:81448
78. Rombouts Y, Ewing E, van de Stadt LA, Selman MH, Trouw LA, Deelder AM, Huizinga TW, Wuhrer M, van Schaardenburg D, Toes RE, Scherer HU (2013) Anticitrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis. doi: 10.1136/annrheumdis-2013-203565
79. Ackerman ME, Crispin M, Yu X, Baruah K, Boesch AW, Harvey DJ, Dugast AS, Heizen EL, Ercan A, Choi I, Streeck H, Nigrovic PA, Bailey-Kellogg C, Scanlan C, Alter G (2013) Natural variation in Fc glycosylation of HIVspecifi c antibodies impacts antiviral activity. J Clin Invest 123:2183-2192
80. Ercan A, Cui J, Chatterton DE, Deane KD, Hazen MM, Brintnell W, O’Donnell CI, Derber LA, Weinblatt ME, Shadick NA, Bell DA, Cairns E, Solomon DH, Holers VM, Rudd PM, Lee DM (2010) Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum 62:2239-2248